Tvardi Therapeutics (TVRD) Revenue (2013 - 2025)
Tvardi Therapeutics (TVRD) reported Revenue of $2.57 million for Q1 2025, up 20.3% from $2.14 million a year earlier and up 76.6% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Revenue (2013 - 2025) Analysis & Trends
Over the twelve months ended Mar 31, 2025, Tvardi Therapeutics' Revenue came in at $7.57 million, down 55.3% year-over-year; for FY2024, it came in at $7.14 million, down 66.0% from FY2023.
- Revenue has a five-year compound annual growth rate of -18.5% (FY2019 to FY2024).
- By year, Revenue came in at $20.97 million in FY2023 (-49.9%), $41.87 million in FY2022 (+81.8%), $23.03 million in FY2021 (-83.0%) and $135.08 million in FY2020 (+579.3%).
- The Q1 2025 figure ranks as the highest quarterly Revenue since Q4 2023.
- Year over year, Revenue gained in 1 of the last eight quarters, with an average decline of 45.3%.
- The high point for year-over-year Revenue in five years was Q4 2022 (growth of 297.2%); the low point was Q4 2021 (a decline of 99.3%).
- Per Business Quant data, the three quarters before Q1 2025 came in at $1.46 million (Q4 2024), $2.56 million (Q3 2024) and $991,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Tvardi Therapeutics | 9.71 Mn | -98.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 2.57 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 991,000.00 |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 4.87 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Mar 31, 2023 | 6.17 Mn |
| Dec 31, 2022 | 3.26 Mn |
| Sep 30, 2022 | 10.81 Mn |
| Jun 30, 2022 | 23.00 Mn |
| Mar 31, 2022 | 4.79 Mn |
| Dec 31, 2021 | 821,000.00 |
| Sep 30, 2021 | 20.27 Mn |
| Mar 31, 2021 | 1.94 Mn |
| Dec 31, 2020 | 112.09 Mn |
| Sep 30, 2020 | 9.27 Mn |
| Jun 30, 2020 | 5.63 Mn |
| Mar 31, 2020 | 8.09 Mn |
API Access
Tvardi Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();